Broadfin Healthcare Master Fund Ltd, 10% Owner at Recro Pharma, Inc. (REPH), bought 390,000 shares at $7.50 ($2.9M) on 2016-08-16, disclosed to the SEC on 2016-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| REPH | SELL | 2017-12-14 | $1.5M | — | Filing → |
| REPH | SELL | 2017-12-07 | $1.0M | — | Filing → |
| PETX | SELL | 2017-12-01 | $5.1M | — | Filing → |